| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168 |
| filingDate |
2017-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_556748843d26b1f6693353a0f9e8d7a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22cbce8c477f3d5802189fcb11ba68d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c7a16f619968af7c285c6eadc4e01e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9f909f24a32dffd8de4286104191412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6a1a76e3c0e3a141462001980178d4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8558155e179a1119eae94e203f8b6db0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b144e5aaab05b1f53fd7eb37101a7584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f0b3223586971b8132ea70d856c4f8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c05636a0a90c6f6d04fc51029072241 |
| publicationDate |
2017-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9849113-B2 |
| titleOfInvention |
Methods of treating α adrenergic mediated conditions |
| abstract |
Described herein are compounds for and methods of treating conditions or diseases in a subject by administering to the subject a pharmaceutical composition containing an effective amount of an α-adrenergic modulator. The compounds and methods are also useful for alleviating types of pain, acute, neuropathic and chronic. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10251865-B2 |
| priorityDate |
2008-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |